TRANXENE Drug Patent Profile
✉ Email this page to a colleague
When do Tranxene patents expire, and when can generic versions of Tranxene launch?
Tranxene is a drug marketed by Ajenat Pharms and is included in one NDA.
The generic ingredient in TRANXENE is clorazepate dipotassium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tranxene
A generic version of TRANXENE was approved as clorazepate dipotassium by AUROBINDO PHARMA on July 17th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRANXENE?
- What are the global sales for TRANXENE?
- What is Average Wholesale Price for TRANXENE?
Summary for TRANXENE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Clinical Trials: | 3 |
Patent Applications: | 339 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRANXENE |
What excipients (inactive ingredients) are in TRANXENE? | TRANXENE excipients list |
DailyMed Link: | TRANXENE at DailyMed |
Recent Clinical Trials for TRANXENE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assistance Publique - Hôpitaux de Paris | Phase 3 |
Polish Lymphoma Research Group | Phase 4 |
Ranbaxy Laboratories Limited | N/A |
US Patents and Regulatory Information for TRANXENE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ajenat Pharms | TRANXENE | clorazepate dipotassium | CAPSULE;ORAL | 017105-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ajenat Pharms | TRANXENE SD | clorazepate dipotassium | TABLET;ORAL | 017105-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ajenat Pharms | TRANXENE | clorazepate dipotassium | TABLET;ORAL | 017105-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRANXENE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ajenat Pharms | TRANXENE | clorazepate dipotassium | TABLET;ORAL | 017105-008 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ajenat Pharms | TRANXENE | clorazepate dipotassium | CAPSULE;ORAL | 017105-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Ajenat Pharms | TRANXENE | clorazepate dipotassium | CAPSULE;ORAL | 017105-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRANXENE
See the table below for patents covering TRANXENE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Yugoslavia | 32996 | ⤷ Sign Up | |
France | 4206 | ⤷ Sign Up | |
Denmark | 135590 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |